| Schedule of disaggregated revenue |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | | | Diagnostics | | | Therapeutic Devices | | | Development Services | | | Consolidated | | | | 2026 | | | 2025 | | | 2026 | | | 2025 | | | 2026 | | | 2025 | | | 2026 | | | 2025 | Capital | | $ | 210 | | $ | 228 | | $ | 1,626 | | $ | 1,425 | | $ | 3 | | $ | - | | $ | 1,839 | | $ | 1,653 | Consumables | | | 1,175 | | | 553 | | | 5,112 | | | 4,739 | | | 362 | | | - | | | 6,649 | | | 5,292 | Engineering | | | - | | | - | | | - | | | - | | | 979 | | | - | | | 979 | | | - | Other | | | - | | | - | | | 16 | | | 19 | | | 29 | | | - | | | 45 | | | 19 | Total revenue | | $ | 1,385 | | $ | 781 | | $ | 6,754 | | $ | 6,183 | | $ | 1,373 | | $ | - | | $ | 9,512 | | $ | 6,964 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | Six Months Ended June 30, | | | | Diagnostics | | | Therapeutic Devices | | | Development Services | | | Consolidated | | | | 2026 | | | 2025 | | | 2026 | | | 2025 | | | 2026 | | | 2025 | | | 2026 | | | 2025 | Capital | | $ | 377 | | $ | 384 | | $ | 3,059 | | $ | 3,225 | | $ | 377 | | $ | - | | $ | 3,813 | | $ | 3,609 | Consumables | | | 1,974 | | | 956 | | | 9,481 | | | 8,833 | | | 664 | | | - | | | 12,119 | | | 9,789 | Engineering | | | - | | | - | | | - | | | - | | | 2,223 | | | - | | | 2,223 | | | - | Other | | | - | | | - | | | 35 | | | 66 | | | 121 | | | - | | | 156 | | | 66 | Total revenue | | $ | 2,351 | | $ | 1,340 | | $ | 12,575 | | $ | 12,124 | | $ | 3,385 | | $ | - | | $ | 18,311 | | $ | 13,464 |
|